Profil
Sam Barker worked as a Director of Business Development at Biodexa Pharmaceuticals Plc from 2020 to 2021.
Prior to that, he worked as a Senior Business Development and Alliance Manager at PhoreMost Ltd.
Dr. Barker received his undergraduate and doctorate degrees from The University of Exeter.
Anciens postes connus de Sam Barker
| Sociétés | Poste | Fin |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Directeur/Membre du Conseil | 01/08/2021 |
PhoreMost Ltd.
 PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Formation de Sam Barker
| The University of Exeter | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIODEXA PHARMACEUTICALS PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
PhoreMost Ltd.
PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom. | Health Technology |